Symproic (naldemedine) / Shionogi, Collegium Pharma 
Welcome,         Profile    Billing    Logout  

7 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Symproic (naldemedine) / Shionogi, Collegium Pharma
ChiCTR2200061564: A study of efficacy and safety of Naldemedine in cancer patients with opioid-induced constipation (OIC)

Not yet recruiting
4
12
 
Naldemedine tablet
Hainan General Hospital; Hainan General Hospital, Supported by Ping An-Shionogi Co., Ltd.
Opioid-induced constipation
 
 
2021-000069-34: The effects of peripheral opioid receptor antagonism on recurrent acute pancreatitis Effekten af perifer opioid antagonisme på recidiverende akut pankreatitis

Ongoing
2/3
120
Europe
Naldemedine 0.2mg Film-coated Tablet, Film-coated tablet
Mech-Sense, Aalborg University Hospital, The Novo Nordisk Foundation, Shionogi B.V.
Recurrent acute pancreatitis, Recurrent acute inflammation of the pancreas, Diseases [C] - Digestive System Diseases [C06]
 
 
NCT04966559 / 2021-000069-34: Effects of a Peripherally Acting µ-opioid Receptor Antagonist on Recurrent Acute Pancreatitis

Active, not recruiting
2/3
74
Europe
Placebo treatment, Naldemedine 0.2 MG Oral Tablet
Asbjørn Mohr Drewes, Odense University Hospital, Hvidovre University Hospital, University Hospital Bispebjerg and Frederiksberg, Karolinska University Hospital
Pancreatitis, Acute
03/24
06/24
NCT06334198: The Effect of Naldemedine on Opioid-induced Bowel Dysfunction

Recruiting
2
20
Europe
Naldemedine, Placebo, Tramadol
Asbjørn Mohr Drewes
Opioid-Induced Bowel Dysfunction, Constipation
03/25
03/25
NCT05588323 / 2019-003577-25: Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving Opioids

Recruiting
1/2
24
Europe
Naldemedine, Rizmoic
Shionogi, Shionogi & Co. Ltd
Opioid-Induced Constipation (OIC)
08/24
08/24
jRCTs031200397: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of the Preventive Effect of Naldemedine on Opioid-Induced Constipation

Completed
N/A
100
Japan
Symproic (naldemedine) - Shionogi, Collegium Pharma
University of Tsukuba Hospital, Japanese Society for Palliative Medicine
Neoplasms
 
 
NCT03720613: Risk of Major Adverse Cardiovascular Events for Naldemedine and Other Medications for Opioid Induced Constipation in Adults With Chronic Non-Cancer Pain

Recruiting
N/A
34532
US
Naldemedine, Symproic®, Lubiprostone, Amitiza®, Naloxegol, Movantik®
BioDelivery Sciences International, HealthCore, Inc.
Opioid-induced Constipation
11/30
11/30

Download Options